Non-Hodgkin's Lymphoma, Phase I
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Volunteers
Health Professionals
What is the purpose of this trial?
This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Alfredo Axtmayer, APRN
- D. Barry Boyd, MD, MS
- Elan Gorshein, DO, JD, MPH
- Emily Kopas, APRN, OCN
- Ethan Kohn, PA
- Francesca Montanari, MD
- Iris Isufi, MD
- Jadwiga Kretowicz, APRN
- Justine Boulanger-Parzych, APRN
- Larisa Fleysher, APRN
- Natalia Neparidze, MD
- Sabrina Browning, MD
- Scott Huntington, MD, MPH, MSc
- Shalin Kothari, MD
- Stephanie Halene, MD, Dr Med
- Stuart Seropian, MD
- Tarsheen Sethi, MD, MSc
- Terri Parker, MD
- Last Updated04/08/2026
- Study IRB#2000037506